The highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in single-dose vials for $499 per month through LillyDirect’s Self Pay Pharmacy Solutions and the Zepbound Self Pay Journey Program.
Read More
New research identifies five clinically relevant prescribing cascades in a national sample of older adults in Ireland.
Read More
It is now expanding its reach to address the growing global demand for guidance around whole-day health.
Read More
He succeeds co-founder Johnny Goodman, who will remain active on the board.
Read More
The pan-K+ channel inhibitor, delivered via nasal spray, is designed to restore natural airway reflexes during sleep by activating pressure-sensing nerves in the nasopharynx.
Read More